Rajamanickam Anuradha, Ann Daniel Evangeline, Dasan Bindu, Thiruvengadam Kannan, Chandrasekaran Padmapriyadarsini, Gaikwad Sanjay, Pattabiraman Sathyamurthi, Bhanu Brindha, Sivaprakasam Amsaveni, Kulkarni Vandana, Karyakarte Rajesh, Paradkar Mandar, Shivakumar Shri Vijay Bala Yogendra, Mave Vidya, Gupta Amita, Hanna Luke Elizabeth, Babu Subash
National Institute of Health-National Institute of Allergy and Infectious Diseases-International Center for Excellence in Research, Chennai, India.
ICMR-National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai, India.
J Infect Dis. 2025 Mar 17;231(3):696-705. doi: 10.1093/infdis/jiae365.
The progression from Mycobacterium tuberculosis infection to active tuberculosis disease varies among individuals, and identifying biomarkers to predict progression is crucial for guiding interventions. In this study, we aimed to determine plasma immune biomarker profiles in healthy household contacts of index patients with pulmonary tuberculosis, who either progressed to tuberculosis or remained as nonprogressors.
A cohort of household contacts of adults with pulmonary tuberculosis was enrolled, consisting of 15 contacts who progressed to tuberculosis disease and 15 nonprogressors. Plasma samples were collected at baseline, 4 months, and 12 months to identify predictive tuberculosis progression markers.
Our findings revealed that individuals in the progressor group exhibited significantly decreased levels of interferon (IFN) γ, tumor necrosis factor α, interleukin 2, IL-1α, IL-1β, and 17A, and interleukin 1 receptor antagonist (IL-1Ra) at baseline, month 4, and month 12. In contrast, the progressor group displayed significantly elevated levels of IFN-α, IFN-β, interleukin 6 and 12, granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 10 (IL-10) and 33 (IL-33), CCL2, CCL11, CXCL8, CXCL10, CX3CL1, vascular endothelial growth factor, granzyme B, and programmed death ligand -1 compared to the nonprogressor group at baseline, months 4 and 12. Receiver operating characteristic analysis (ROC) identified IFN-γ, GM-CSF, IL-1Ra, CCL2, and CXCL10 as the most promising predictive markers, with an area under the receiver operating characteristic curve of ≥90. Furthermore, combinatorial analysis demonstrated that GM-CSF, CXCL10, and IL-1Ra, when used in combination, exhibited high accuracy in predicting progression to active tuberculosis disease.
Our study suggests that a specific set of plasma biomarkers, GM-CSF, CXCL10, and IL-1Ra, can effectively identify household contacts at significant risk of developing tuberculosis disease. These findings have important implications for early intervention and preventive strategies in tuberculosis-endemic regions.
从结核分枝杆菌感染进展为活动性结核病在个体间存在差异,识别预测疾病进展的生物标志物对于指导干预措施至关重要。在本研究中,我们旨在确定肺结核指数患者的健康家庭接触者的血浆免疫生物标志物谱,这些接触者要么进展为结核病,要么仍为未进展者。
招募了一组成年肺结核患者的家庭接触者,包括15名进展为结核病的接触者和15名未进展者。在基线、4个月和12个月时采集血浆样本,以识别预测结核病进展的标志物。
我们的研究结果显示,进展组个体在基线、第4个月和第12个月时,干扰素(IFN)γ、肿瘤坏死因子α、白细胞介素2、IL-1α、IL-1β和17A以及白细胞介素1受体拮抗剂(IL-1Ra)的水平显著降低。相比之下,与未进展组在基线、第4个月和第12个月时相比,进展组的IFN-α、IFN-β、白细胞介素6和12、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、白细胞介素10(IL-10)和33(IL-33)、CCL2、CCL11、CXCL8、CXCL10、CX3CL1、血管内皮生长因子、颗粒酶B和程序性死亡配体-1水平显著升高。受试者工作特征分析(ROC)确定IFN-γ、GM-CSF、IL-1Ra、CCL2和CXCL10为最有前景的预测标志物,受试者工作特征曲线下面积≥90。此外,组合分析表明,GM-CSF、CXCL10和IL-1Ra联合使用时,在预测进展为活动性结核病方面具有很高的准确性。
我们的研究表明,一组特定的血浆生物标志物,即GM-CSF、CXCL10和IL-1Ra,能够有效识别有患结核病重大风险的家庭接触者。这些发现对结核病流行地区的早期干预和预防策略具有重要意义。